This compound sits directly upstream of the amino-alcohol intermediate ((R)-2-((4-Aminophenethyl)amino)-1-phenylethan-1-ol) in the mirabegron synthetic pathway: reduction of its nitro group to an amine, coupled with reduction of the amide carbonyl to an amine linkage, generates that downstream intermediate. As a fully characterized reference material compliant with USP, EMA, JP, and BP standards, it is essential for supporting ANDA and NDA regulatory submissions and commercial mirabegron production quality control.
(R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide, designated Mirabegron EP Impurity G (also known as Mirabegron INT 1), is a chiral hydroxyamide bearing a nitrophenyl substituent that serves as a key upstream synthetic intermediate in the manufacturing route to mirabegron, a selective ß3-adrenergic receptor agonist indicated for overactive bladder syndrome.
| Chemical Name | (R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide (Mirabegron EP Impurity G) |
| CAS Number | 521284-19-5 |
| IUPAC Name | (R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide |
| Molecular Formula | C16H16N2O4 |
| Molecular Weight | 300.31 g/mol g/mol |
Direct upstream synthetic intermediate in the multi-step industrial route to mirabegron.
Designated Mirabegron EP Impurity G for European Pharmacopoeia-compliant drug substance quality control.
Used in ANDA and NDA filings requiring characterized impurity reference materials for mirabegron.
Supports HPLC method validation for mirabegron process impurity monitoring.
J. Med. Chem.
Org. Process Res. Dev. (process chemistry reference)
Our R&D centers specialize in the design and process development of complex heterocyclic and chiral molecules — mg to kg scale.